• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GRACE风险评分在非ST段抬高型心肌梗死合并非阻塞性冠状动脉疾病患者中的预后价值

Prognostic Value of GRACE Risk Scores in Patients With Non-ST-Elevation Myocardial Infarction With Non-obstructive Coronary Arteries.

作者信息

Yin Guoqing, Abdu Fuad A, Liu Lu, Xu Siling, Xu Bin, Luo Yanru, Lv Xian, Fan Rui, Che Wenliang

机构信息

Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

Department of Cardiology, Clinical Medical College of Shanghai Tenth People's Hospital, Nanjing Medical University, Shanghai, China.

出版信息

Front Cardiovasc Med. 2021 Feb 16;8:582246. doi: 10.3389/fcvm.2021.582246. eCollection 2021.

DOI:10.3389/fcvm.2021.582246
PMID:33665209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7920981/
Abstract

Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a special type of myocardial infarction (MI). The GRACE risk score is commonly used to predict major adverse cardiovascular events (MACE) in non-ST-elevation myocardial infarction patients, and the suitability of the GRACE risk score for prognostic stratification in patients with MINOCA remains uncertain. This study aimed to investigate whether the GRACE risk score is capable of predicting MACE in MINOCA patients with NSTE. We calculated the GRACE risk score for 340 consecutive MINOCA patients with NSTE. Patients were divided into a low-intermediate risk group (≤ 140, 48.8%) and a high risk group (>140, 51.2%) according to their GRACE risk scores. The clinical characteristics and outcomes of the patients were assessed. Patients in the high risk group tended to be older and to have more comorbidities. At the 1-year follow-up, the rate of cardiac death in the high risk group was significantly higher than that in the low-intermediate-risk group ( = 0.010). There was no significant difference in non-fatal MI, stroke, heart failure, or cardiovascular-related rehospitalization. The incidence of total MACE was significantly higher in patients with high GRACE risk scores than in patients with low GRACE risk scores ( = 0.006). ROC curve analysis showed that the GRACE risk score has moderate value in predicting MACE in NSTE-MINOCA patients. The area under the ROC curve was 0.710 (95% CI 0.625-0.796, < 0.001). The GRACE risk score provides potentially valuable prognostic information on clinical outcome when applied to MINOCA patients with NSTE.

摘要

非阻塞性冠状动脉心肌梗死(MINOCA)是一种特殊类型的心肌梗死(MI)。GRACE风险评分常用于预测非ST段抬高型心肌梗死患者的主要不良心血管事件(MACE),而GRACE风险评分在MINOCA患者预后分层中的适用性仍不确定。本研究旨在调查GRACE风险评分是否能够预测NSTE的MINOCA患者的MACE。我们计算了340例连续的NSTE的MINOCA患者的GRACE风险评分。根据GRACE风险评分,患者被分为低-中风险组(≤140,48.8%)和高风险组(>140,51.2%)。评估了患者的临床特征和结局。高风险组的患者往往年龄更大且合并症更多。在1年随访时,高风险组的心源性死亡率显著高于低-中风险组(=0.010)。在非致命性MI、中风、心力衰竭或心血管相关再住院方面无显著差异。GRACE风险评分高的患者的总MACE发生率显著高于GRACE风险评分低的患者(=0.006)。ROC曲线分析表明,GRACE风险评分在预测NSTE-MINOCA患者的MACE方面具有中等价值。ROC曲线下面积为0.710(95%CI 0.625-0.796,<0.001)。当应用于NSTE的MINOCA患者时,GRACE风险评分可为临床结局提供潜在有价值的预后信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3c/7920981/78fd6791ad4b/fcvm-08-582246-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3c/7920981/78fd6791ad4b/fcvm-08-582246-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3c/7920981/78fd6791ad4b/fcvm-08-582246-g0001.jpg

相似文献

1
Prognostic Value of GRACE Risk Scores in Patients With Non-ST-Elevation Myocardial Infarction With Non-obstructive Coronary Arteries.GRACE风险评分在非ST段抬高型心肌梗死合并非阻塞性冠状动脉疾病患者中的预后价值
Front Cardiovasc Med. 2021 Feb 16;8:582246. doi: 10.3389/fcvm.2021.582246. eCollection 2021.
2
Long-term outcomes and predictors of patients with ST elevated versus non-ST elevated myocardial infarctions in non-obstructive coronary arteries: a retrospective study in Northern China.非阻塞性冠状动脉中 ST 段抬高与非 ST 段抬高心肌梗死患者的长期结局和预测因素:中国北方的一项回顾性研究。
PeerJ. 2023 Mar 3;11:e14958. doi: 10.7717/peerj.14958. eCollection 2023.
3
Clinical characteristics and outcome in patients with ST-segment and non-ST-segment elevation myocardial infarction without obstructive coronary artery: an observation study from Chinese population.无阻塞性冠状动脉病变的 ST 段抬高和非 ST 段抬高心肌梗死患者的临床特征和转归:一项来自中国人群的观察性研究。
BMC Cardiovasc Disord. 2022 Jan 29;22(1):21. doi: 10.1186/s12872-021-02359-x.
4
Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study.三种基于炎症的格拉斯哥预后评分对急性心肌梗死患者住院期间主要心血管不良事件的预测价值:一项回顾性研究
PeerJ. 2020 Apr 24;8:e9068. doi: 10.7717/peerj.9068. eCollection 2020.
5
Clinical Outcomes and Predictors of ST-Elevation Versus Non-ST-Elevation Myocardial Infarction with Non-Obstructive Coronary Arteries.非阻塞性冠状动脉疾病的 ST 段抬高与非 ST 段抬高心肌梗死的临床转归和预测因素。
Am J Med Sci. 2020 Dec;360(6):686-692. doi: 10.1016/j.amjms.2020.07.016. Epub 2020 Jul 14.
6
Value of GRACE and SYNTAX scores for predicting the prognosis of patients with non-ST elevation acute coronary syndrome.GRACE评分和SYNTAX评分对预测非ST段抬高型急性冠状动脉综合征患者预后的价值。
World J Clin Cases. 2021 Nov 26;9(33):10143-10150. doi: 10.12998/wjcc.v9.i33.10143.
7
Risk stratification and prognostic value of grace and timi risk scores for female patients with non-st segment elevation acute coronary syndrome.非ST段抬高型急性冠状动脉综合征女性患者的GRACE和TIMI风险评分的风险分层及预后价值
Int J Clin Exp Med. 2015 Mar 15;8(3):4038-44. eCollection 2015.
8
Risk stratification and prognostic value of GRACE and TIMI risk scores for female patients with non-ST segment elevation acute coronary syndrome.GRACE和TIMI风险评分对非ST段抬高型急性冠状动脉综合征女性患者的风险分层及预后价值
Minerva Cardioangiol. 2015 Jun;63(3):171-8. Epub 2014 Dec 11.
9
[Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].非ST段抬高型急性冠状动脉综合征患者血浆N末端脑钠肽前体与GRACE危险分层的关系
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 May;40(5):373-7.
10
Performance of Prognostic Scoring Systems in MINOCA: A Comparison among GRACE, TIMI, HEART, and ACEF Scores.心肌梗死伴非阻塞性冠状动脉病变(MINOCA)中预后评分系统的性能:全球急性冠状动脉事件注册研究(GRACE)、心肌梗死溶栓治疗(TIMI)、心肌梗死全球登记处(HEART)和急性冠状动脉事件全球注册欧洲分支(ACEF)评分的比较
J Clin Med. 2023 Aug 31;12(17):5687. doi: 10.3390/jcm12175687.

引用本文的文献

1
Prognostic Value of PRECİSE DAPT Score on Short- and Long-Term Outcomes in MINOCA Patients with Acute Coronary Syndrome.PRECİSE DAPT 评分对急性冠状动脉综合征伴 MINOCA 患者短期和长期结局的预测价值。
Arq Bras Cardiol. 2024 Sep;121(5):e20230791. doi: 10.36660/abc.20230791.
2
Performance of Prognostic Scoring Systems in MINOCA: A Comparison among GRACE, TIMI, HEART, and ACEF Scores.心肌梗死伴非阻塞性冠状动脉病变(MINOCA)中预后评分系统的性能:全球急性冠状动脉事件注册研究(GRACE)、心肌梗死溶栓治疗(TIMI)、心肌梗死全球登记处(HEART)和急性冠状动脉事件全球注册欧洲分支(ACEF)评分的比较
J Clin Med. 2023 Aug 31;12(17):5687. doi: 10.3390/jcm12175687.
3
[Pathophysiology and diagnostic and therapeutic algorithm of MINOCA].

本文引用的文献

1
Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non-Obstructive Coronary Arteries.非阻塞性冠状动脉心肌梗死患者的预后和死亡预测因素。
J Am Heart Assoc. 2019 Jul 16;8(14):e011990. doi: 10.1161/JAHA.119.011990. Epub 2019 Jul 9.
2
Predictors of Mortality in Myocardial Infarction and Nonobstructed Coronary Arteries: A Systematic Review and Meta-Regression.非阻塞性冠状动脉疾病心肌梗死患者死亡的预测因素:系统评价和荟萃回归分析。
Am J Med. 2020 Jan;133(1):73-83.e4. doi: 10.1016/j.amjmed.2019.05.048. Epub 2019 Jun 29.
3
Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.
[心肌梗死伴非阻塞性冠状动脉病变的病理生理学及诊断与治疗流程]
Rev Fac Cien Med Univ Nac Cordoba. 2023 Mar 31;80(1):36-42. doi: 10.31053/1853.0605.v80.n1.36817.
非阻塞性冠状动脉所致心肌梗死与阻塞性冠状动脉疾病所致心肌梗死的比较:医疗保险人群的结局
Eur Heart J. 2020 Feb 14;41(7):870-878. doi: 10.1093/eurheartj/ehz403.
4
Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.当代非阻塞性冠状动脉疾病患者心肌梗死的诊断与管理:美国心脏协会科学声明。
Circulation. 2019 Apr 30;139(18):e891-e908. doi: 10.1161/CIR.0000000000000670.
5
Myocardial infarction with non-obstructive coronary arteries (MINOCA) in Chinese patients: Clinical features, treatment and 1 year follow-up.中国患者的非阻塞性冠状动脉心肌梗死(MINOCA):临床特征、治疗和 1 年随访。
Int J Cardiol. 2019 Jul 15;287:27-31. doi: 10.1016/j.ijcard.2019.02.036. Epub 2019 Feb 20.
6
Fourth Universal Definition of Myocardial Infarction (2018).心肌梗死的第四次全球定义(2018年)。
Circulation. 2018 Nov 13;138(20):e618-e651. doi: 10.1161/CIR.0000000000000617.
7
Accuracy of the Global Registry of Acute Coronary Events (GRACE) Risk Score in Contemporary Treatment of Patients With Acute Coronary Syndrome.全球急性冠状动脉事件登记处(GRACE)风险评分在急性冠状动脉综合征患者当代治疗中的准确性。
Can J Cardiol. 2018 Dec;34(12):1613-1617. doi: 10.1016/j.cjca.2018.09.015. Epub 2018 Oct 12.
8
Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries.非阻塞性冠状动脉性首发性心肌梗死的发病率和病因特异性死亡率。
J Intern Med. 2019 Apr;285(4):419-428. doi: 10.1111/joim.12857. Epub 2018 Nov 25.
9
Outcome after myocardial infarction without obstructive coronary artery disease.非阻塞性冠状动脉疾病心肌梗死后的结果。
Heart. 2019 Apr;105(7):524-530. doi: 10.1136/heartjnl-2018-313665. Epub 2018 Sep 29.
10
Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study.非阻塞性冠状动脉心肌梗死(MINOCA)年轻患者的临床表现、临床特征和预后:VIRGO 研究结果。
J Am Heart Assoc. 2018 Jun 28;7(13):e009174. doi: 10.1161/JAHA.118.009174.